Sign up for email alert when new content gets added: Sign up
OBJECTIVE: We have been given the task of studying the evolution of T2DM and alterations in glucose homeostasis in patients undergoing bariatric/metabolic surgery and determine if there is remission of T2DM in our patients undergoing vertical sleeve gastrectomy or Roux-en-Y gastric bypass and, if so, after which one is greater.
METHODS: Descriptive, observational, longitudinal and retrospective analysis of data from patients with diagnosis of obesity (BMI ≥ 30 kg/m2) and T2DM who underwent SG or RYGB at our obesity clinic, from March 2015 to March 2016. Diabetes remission was defined as glucose below the diagnostic thresholds for T2DM (HbA1c<6%, fasting glucose<100 mg/dl if HbA1c was not available) and absence of active hypoglycemic medication.
RESULTS: Bariatric/metabolic surgery can reverse or improve T2DM in obese patients, and is more effective than medical interventions and lifestyle modifications for weight loss, glycemic control, remission of T2DM, improvements in other cardiovascular risk factors and the decrease ofcardiovascular diseases
